Skip to main content

Table 2 Organization and opioid use disorder (OUD) treatment characteristics of participating community treatment program sites (n = 7)

From: The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study

 

Community treatment program sites

(n = 7)

Organization characteristics, n (%)

 Type of organization

  Opioid treatment program

2 (28.6%)

  Stand-alone outpatient medical or behavioral health center

2 (28.6%)

  Tertiary care medical center

1 (14.3%)

  Health department

1 (14.3%)

  Other

1 (14.3%)

 Contract or treatment track for justice-involved adults with OUD

4 (57.1%)

Opioid use disorder (MOUD) treatment characteristics, n (%)

 MOUD prescribed for:

  Opioid withdrawal management

5 (71.4%)

  Maintenance for adults with OUD

5 (71.4%)

  Maintenance for pregnant women

4 (57.1%)

  Maintenance for juveniles

1 (14.3%)

 Medications available within organization/facility

  Methadone

2 (28.6%)

  Sublingual buprenorphine

5 (71.4%)

  Extended-release buprenorphine

4 (57.1%)

  Sublingual buprenorphine/naloxone

5 (71.4%)

  Extended-release naltrexone

6 (85.7%)

  Oral naltrexone

5 (71.4%)

 Available non-medication treatment for SUDs offered to carceral-involved patients

  Outpatient substance use treatment

5 (71.4%)

  Co-occurring substance use and mental health services

5 (71.4%)

  Intensive outpatient treatment

4 (57.1%)

  Peer mentor/navigator/recovery coach

4 (57.1%)

  Mutual- or self-help group meetings

2 (28.6%)

  Transfer to residential treatment/inpatient treatment

2 (28.6%)

  Other: Opioid treatment program

1 (14.3%)

Telemedicine use, n (%)

 Prior to COVID-19, use of telemedicine for:

  Treatment of any health condition

2 (33.3%)

  Inducting patients on MOUD

1 (16.7%)

  Maintaining patients on MOUD

2 (33.3%)

 Use of technology/methods used by patients with OUD to participate in substance use treatment or recovery support

  Video calls

6 (85.7%)

  Computers

6 (85.7%)

  Cell phones

6 (85.7%)

  Tablets

5 (71.4%)

  Text messaging

5 (71.4%)

  Email

4 (57.1%)

  Internet

4 (57.1%)

  Other applications or software programs: Zoom and reSET

1 (14.3%)

  Kiosks

1 (14.3%)

  Portable kiosks

0 (0%)

Wraparound services and other supports, n (%)

 Program provides naloxone kits

7 (100%)

 Naloxone kits provided to:

  Everyone

2 (28.6%)

  Only individuals with opioid use problems/OUD

3 (42.9%)

  Other:

Offered to all OUD patients; Kit/prescription provided to anyone who asks

We have them on hand to administer in the office if needed

2 (28.6%)